Cargando…
Moving toward genome-editing therapies for cardiovascular diseases
The rapid invention of genome-editing technologies over the past decade, which has already been transformative for biomedical research, has raised the tantalizing prospect of an entirely new therapeutic modality. Whereas the treatment of chronic cardiovascular diseases has heretofore entailed the us...
Autor principal: | Musunuru, Kiran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718140/ https://www.ncbi.nlm.nih.gov/pubmed/34981785 http://dx.doi.org/10.1172/JCI148555 |
Ejemplares similares
-
Genome editing of human pluripotent stem cells to generate human cellular disease models
por: Musunuru, Kiran
Publicado: (2013) -
Angiopoietin-Like 3: From Discovery to Therapeutic Gene Editing
por: Wang, Xiao, et al.
Publicado: (2019) -
Base editing: a brief review and a practical example
por: Choe, Dongwook C., et al.
Publicado: (2021) -
Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention
por: Musunuru, Kiran
Publicado: (2010) -
Adenine base editing to treat progeria syndrome and extend the lifespan
por: Musunuru, Kiran
Publicado: (2021)